Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (171-180 of 329) with videos related to

Pageof 33
Sort By:
AIDS (London, England)|March 29, 2017
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumabGwenaëlle Le Garff, Assia Samri, Sidonie Lambert-Niclot, et al.
Rheumatology (Oxford, England)|October 11, 2011
Idiopathic interstitial lung disease with anti-SSA antibodyJean-François Boitiaux, Marie-Pierre Debray, Pascale Nicaise-Roland, et al.
Therapeutic Advances in Respiratory Disease|June 8, 2021
Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective studyThomas Maitre, Vichita Ok, Ruxandra Calin, et al.
The Journal of Infectious Diseases|October 24, 2007
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated diseaseAnne-Geneviève Marcelin, Jérome Motol, Amélie Guihot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2009
IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtypeJacques Cadranel, Elisabeth Quoix, Laurence Baudrin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1)Vera Hirsh, Jacques Cadranel, Xiuyu Julie Cong, et al.
Respiration; International Review of Thoracic Diseases|July 9, 2018
Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future PerspectivesAna Alastruey-Izquierdo, Jacques Cadranel, Holger Flick, et al.
Respiratory Medicine|July 22, 2008
ANCA-associated lung fibrosis: analysis of 17 patientsGuillaume Foulon, Philippe Delaval, Dominique Valeyre, et al.
Blood|April 9, 2004
Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphomaSimona Zompi, Louis-Jean Couderc, Jacques Cadranel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2014
Prospective screening for ALK: clinical features and outcome according to ALK statusVincent Fallet, Jacques Cadranel, Hélène Doubre, et al.
Pageof 33

Showing results (171-180 of 329) with videos related to

Sort By:
Pageof 33
AIDS (London, England)|March 29, 2017
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumabGwenaëlle Le Garff, Assia Samri, Sidonie Lambert-Niclot, et al.
Rheumatology (Oxford, England)|October 11, 2011
Idiopathic interstitial lung disease with anti-SSA antibodyJean-François Boitiaux, Marie-Pierre Debray, Pascale Nicaise-Roland, et al.
Therapeutic Advances in Respiratory Disease|June 8, 2021
Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective studyThomas Maitre, Vichita Ok, Ruxandra Calin, et al.
The Journal of Infectious Diseases|October 24, 2007
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated diseaseAnne-Geneviève Marcelin, Jérome Motol, Amélie Guihot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2009
IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtypeJacques Cadranel, Elisabeth Quoix, Laurence Baudrin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1)Vera Hirsh, Jacques Cadranel, Xiuyu Julie Cong, et al.
Respiration; International Review of Thoracic Diseases|July 9, 2018
Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future PerspectivesAna Alastruey-Izquierdo, Jacques Cadranel, Holger Flick, et al.
Respiratory Medicine|July 22, 2008
ANCA-associated lung fibrosis: analysis of 17 patientsGuillaume Foulon, Philippe Delaval, Dominique Valeyre, et al.
Blood|April 9, 2004
Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphomaSimona Zompi, Louis-Jean Couderc, Jacques Cadranel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2014
Prospective screening for ALK: clinical features and outcome according to ALK statusVincent Fallet, Jacques Cadranel, Hélène Doubre, et al.
Pageof 33